Response of thymoma to cetuximab.
Farina
Gabriella
G
Department of Oncology, Fatebenefratelli and Ophthalmic Hospital, Milan, Italy.
Garassino
Marina C
MC
Gambacorta
Marcello
M
La Verde
Nicla
N
Gherardi
Giorgio
G
Scanni
Alberto
A
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000276:immunology; D005260:Female; D006801:Humans; D013945:Thymoma / Q000188:drug therapy*; D013953:Thymus Neoplasms / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab